药品详细
Calcium carbonate(碳酸钙)
化学结构式图
中文名
碳酸钙
英文名
Calcium carbonate
分子式
Not Available
化学名
分子量
Not Available
CAS号
<span class="not-available">Not Available</span>
ATC分类
A02A 未知;A12A 未知
药物类型
small molecule
阶段
approved
商品名
同义名
基本介绍
Calcium carbonate is an inorganic salt used as an antacid. It is a basic compound that acts by neutralizing hydrochloric acid in gastric secretions. Subsequent increases in pH may inhibit the action of pepsin. An increase in bicarbonate ions and prostaglandins may also confer cytoprotective effects. Calcium carbonate may also be used as a nutritional supplement or to treat hypocalcemia.
生产厂家
封装厂家
参考
Synthesis Reference | Not Available |
General Reference | Not Available |
剂型
规格
化合物类型
Type | small molecule |
Classes | Not Available |
Substructures | Not Available |
适应症
药理
Indication | For relief of heartburn and acid indigestion. May also be used as a nutritional supplement or to treat hypocalcemia. |
Pharmacodynamics | Gastric-peptic disease occurs as a result of an imbalance between protective factors, such as mucus, bicarbonate, and prostaglandin secretion, and aggressive factors, such as hydrochloric acid, pepsin, and Helicobacter pylori (H. pylori). Antacids work by restoring acid-base balance, attenuating the pepsin activity and increasing bicarbonate and prostaglandin secretion. The acid-neutralizing capacity of calcium carbonate is 58 mEq/15 ml. When used as a nutritional supplement, calcium carbonate acts by directly increasing calcium stores within the body. |
Mechanism of action | Calcium carbonate is a basic inorganic salt that acts by neutralizing hydrochloric acid in gastric secretions. It also inhibits the action of pepsin by increasing the pH and via adsorption. Cytoprotective effects may occur through increases in bicarbonate ion (HCO3-) and prostaglandins. Neutralization of hydrochloric acid results in the formation of calcium chloride, carbon dioxide and water. Approximately 90% of calcium chloride is converted to insoluble calcium salts (e.g. calcium carbonate and calcium phosphate). |
Absorption | Maximal absorption occurs at doses of 500 mg or less taken with food. Oral bioavailability depends on intestinal pH, the presence of food and dosage. |
Volume of distribution | Calcium is rapidly distributed taken up by skeletal tissues following absorption and distribution into extracellular fluids. Bone contains 99% of the body’s calcium and the remaining 1% is approximately equally distributed between intracellular and extracellular fluids. |
Protein binding | Calcium acts as a co-factor to numerous enzymes. |
Metabolism |
None.
|
Route of elimination | Excreted mainly in the feces. The majority of renally filtered calcium is reabsorbed in the ascending limb of the loop of Henle and the proximal and distal convoluted tubules. Also secreted by sweat glands. |
Half life | Not Available |
Clearance | Not Available |
Toxicity | Not Available |
Affected organisms |
|
Pathways | Not Available |
理化性质
Properties | |
---|---|
State | solid |
Experimental Properties | Not Available |
Predicted Properties | Not Available |
药物相互作用
Drug | Interaction |
---|---|
Calcium Acetate | Calcium salts may enhance the adverse/toxic effect of calcium acetate. Concurrent use of other calcium salts with calcium acetate should be avoided when possible. This combination is particularly dangerous in patients with other risk factors for hypercalcemia, such as those with end-stage renal disease. |
Calcium Chloride | Calcium salts may enhance the adverse/toxic effect of calcium chloride. Concurrent use of other calcium salts with calcium acetate should be avoided when possible. This combination is particularly dangerous in patients with other risk factors for hypercalcemia, such as those with end-stage renal disease. |
Eltrombopag | Decreases levels of eltrombopag by GI absorption inhibition. |
Itraconazole | The antacid, calcium carbonate, may decrease the effect of itraconazole by decreasing its absorption. |
食物相互作用
- Food increases the absorption of calcium carbonate.